174 related articles for article (PubMed ID: 35732988)
21. Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo.
Venneti S; Dunphy MP; Zhang H; Pitter KL; Zanzonico P; Campos C; Carlin SD; La Rocca G; Lyashchenko S; Ploessl K; Rohle D; Omuro AM; Cross JR; Brennan CW; Weber WA; Holland EC; Mellinghoff IK; Kung HF; Lewis JS; Thompson CB
Sci Transl Med; 2015 Feb; 7(274):274ra17. PubMed ID: 25673762
[TBL] [Abstract][Full Text] [Related]
22. Fluorination at the 4 position alters the substrate behavior of L-glutamine and L-glutamate: Implications for positron emission tomography of neoplasias.
Jeitner TM; Kristoferson E; Azcona JA; Pinto JT; Stalnecker C; Erickson JW; Kung HF; Li J; Ploessl K; Cooper AJL
J Fluor Chem; 2016 Dec; 192(A):58-67. PubMed ID: 28546645
[TBL] [Abstract][Full Text] [Related]
23. PET/CT imaging of renal cell carcinoma with (18)F-VM4-037: a phase II pilot study.
Turkbey B; Lindenberg ML; Adler S; Kurdziel KA; McKinney YL; Weaver J; Vocke CD; Anver M; Bratslavsky G; Eclarinal P; Kwarteng G; Lin FI; Yaqub-Ogun N; Merino MJ; Linehan WM; Choyke PL; Metwalli AR
Abdom Radiol (NY); 2016 Jan; 41(1):109-18. PubMed ID: 26830617
[TBL] [Abstract][Full Text] [Related]
24. Side Chain Optimization Remarkably Enhances the in Vivo Stability of
Chen J; Li C; Hong H; Liu H; Wang C; Xu M; Han Y; Liu Z
Mol Pharm; 2019 Dec; 16(12):5035-5041. PubMed ID: 31670970
[TBL] [Abstract][Full Text] [Related]
25. Metabolic Imaging of Glutamine in Cancer.
Zhu L; Ploessl K; Zhou R; Mankoff D; Kung HF
J Nucl Med; 2017 Apr; 58(4):533-537. PubMed ID: 28232608
[TBL] [Abstract][Full Text] [Related]
26. Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents.
Ploessl K; Wang L; Lieberman BP; Qu W; Kung HF
J Nucl Med; 2012 Oct; 53(10):1616-24. PubMed ID: 22935578
[TBL] [Abstract][Full Text] [Related]
27. [
Zhou R; Pantel AR; Li S; Lieberman BP; Ploessl K; Choi H; Blankemeyer E; Lee H; Kung HF; Mach RH; Mankoff DA
Cancer Res; 2017 Mar; 77(6):1476-1484. PubMed ID: 28202527
[TBL] [Abstract][Full Text] [Related]
28. ImmunoPET imaging of renal cell carcinoma with (124)I- and (89)Zr-labeled anti-CAIX monoclonal antibody cG250 in mice.
Stillebroer AB; Franssen GM; Mulders PF; Oyen WJ; van Dongen GA; Laverman P; Oosterwijk E; Boerman OC
Cancer Biother Radiopharm; 2013 Sep; 28(7):510-5. PubMed ID: 23697926
[TBL] [Abstract][Full Text] [Related]
29. Kinetic Modeling of
Viswanath V; Zhou R; Lee H; Li S; Cragin A; Doot RK; Mankoff DA; Pantel AR
J Nucl Med; 2021 Aug; 62(8):1154-1162. PubMed ID: 33277391
[TBL] [Abstract][Full Text] [Related]
30. (2S,4R)-4-[
Zhu H; Liu F; Zhang Y; Yang J; Xu X; Guo X; Liu T; Li N; Zhu L; Kung HF; Yang Z
Mol Imaging Biol; 2019 Oct; 21(5):945-953. PubMed ID: 30793240
[TBL] [Abstract][Full Text] [Related]
31. Automated synthesis of [(18)F](2S,4R)-4-fluoroglutamine on a GE TRACERlab™ FX-N Pro module.
Zhang X; Basuli F; Shi ZD; Xu B; Blackman B; Choyke PL; Swenson RE
Appl Radiat Isot; 2016 Jun; 112():110-4. PubMed ID: 27019029
[TBL] [Abstract][Full Text] [Related]
32. Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [
Baguet T; Verhoeven J; Pauwelyn G; Hu J; Lambe P; De Lombaerde S; Piron S; Donche S; Descamps B; Goethals I; Vanhove C; De Vos F; Beyzavi MH
Nucl Med Biol; 2020; 86-87():20-29. PubMed ID: 32447069
[TBL] [Abstract][Full Text] [Related]
33. Non-Invasive Glutamine PET Reflects Pharmacological Inhibition of BRAF
Schulte ML; Hight MR; Ayers GD; Liu Q; Shyr Y; Washington MK; Manning HC
Mol Imaging Biol; 2017 Jun; 19(3):421-428. PubMed ID: 27770401
[TBL] [Abstract][Full Text] [Related]
34. Benign Adrenal Nodule Mimicking Lymphoma Differentially Diagnosed by 18F-FDG and 18F-FGln PET/CT.
Xu X; Zhu H; Kung HF; Li N; Yang Z
Clin Nucl Med; 2021 Jun; 46(6):474-476. PubMed ID: 33661191
[TBL] [Abstract][Full Text] [Related]
35. Initial experience in synthesis of (2S,4R)-4-[
Zhang Y; Zhang L; Yang J; Wu Z; Ploessl K; Zha Z; Liu F; Xu X; Zhu H; Yang Z; Zhu L; Kung HF
J Labelled Comp Radiopharm; 2019 May; 62(5):209-214. PubMed ID: 30861162
[TBL] [Abstract][Full Text] [Related]
36.
Zhou R; Choi H; Cao J; Pantel A; Gupta M; Lee HS; Mankoff D
J Nucl Med; 2023 Jan; 64(1):131-136. PubMed ID: 35772960
[TBL] [Abstract][Full Text] [Related]
37. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
38. Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.
Grinde MT; Hilmarsdottir B; Tunset HM; Henriksen IM; Kim J; Haugen MH; Rye MB; Mælandsmo GM; Moestue SA
Breast Cancer Res; 2019 May; 21(1):61. PubMed ID: 31088535
[TBL] [Abstract][Full Text] [Related]
39. [
Kim K; Kim H; Bae SH; Lee SY; Kim YH; Na J; Lee CH; Lee MS; Ko GB; Kim KY; Lee SH; Song IH; Cheon GJ; Kang KW; Kim SE; Chung JK; Kim EE; Paek SH; Lee JS; Lee BC; Youn H
Theranostics; 2020; 10(20):9315-9331. PubMed ID: 32802194
[TBL] [Abstract][Full Text] [Related]
40. The Use of PET Imaging for Prognostic Integrin α
Huang CW; Hsieh WC; Hsu ST; Lin YW; Chung YH; Chang WC; Chiu H; Lin YH; Wu CP; Yen TC; Huang FT
Theranostics; 2017; 7(16):4013-4028. PubMed ID: 29109795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
